Status:
COMPLETED
Impact of Tegaderm HP and CHG in Major Catheter Related Infections and Dressing Detachment
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Catheter-Related Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Catheter related infection is a frequent and life threatening event in ICU. A chlorhexidine impregnated sponge has been proven to reduce the rate of major catheter related infections in ICU patients (...
Detailed Description
Inclusion criteria: Patients older than 18 years old with central venous who need a central vein and/or an arterial catheter for an expected duration of more than 48 hours.
Eligibility Criteria
Inclusion
- patients older than 18 years old with a central venous catheter or arterial catheter installed in the study departement for a maximum for 24 hours
Exclusion
- pulmonary arterial catheter
- antiseptic-impregnated catheter
- hemodialysis catheter
- chlorhexidine allergy
- emergency catheter without surgical asepsis
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
1960 Patients enrolled
Trial Details
Trial ID
NCT01189682
Start Date
April 1 2010
End Date
July 1 2011
Last Update
October 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Grenoble
Grenoble, France